Literature DB >> 17610813

Parkinson's disease: return of an old prime suspect.

David Sulzer1, Yvonne Schmitz.   

Abstract

Pacemaking activity in adult substantia nigra (SN) dopamine neurons relies on L-type Ca2+ channels, but a surprising study in Nature by Chan et al. demonstrates that blockade of these channels by dihydropyridines re-establishes the pacemaking driven by sodium and HCN channels found in juvenile SN. This shift protects SN neurons in chemical models of Parkinson's disease (PD), suggesting that elevated intracellular Ca2+ participates in SN cell loss and that dihydropyridines may provide therapy in PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610813     DOI: 10.1016/j.neuron.2007.06.023

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  10 in total

1.  The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach.

Authors:  Sijia Wu; Rita R Fagan; Chayasith Uttamapinant; Lawrence M Lifshitz; Kevin E Fogarty; Alice Y Ting; Haley E Melikian
Journal:  J Neurosci       Date:  2017-08-28       Impact factor: 6.167

Review 2.  Functional Interplay between Dopaminergic and Serotonergic Neuronal Systems during Development and Adulthood.

Authors:  Vera Niederkofler; Tedi E Asher; Susan M Dymecki
Journal:  ACS Chem Neurosci       Date:  2015-03-18       Impact factor: 4.418

3.  Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase.

Authors:  Annika Vaarmann; Sonia Gandhi; Andrey Y Abramov
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

4.  Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model.

Authors:  Xu Zhang; Jian-Ying Zhou; Mark H Chin; Athena A Schepmoes; Vladislav A Petyuk; Karl K Weitz; Brianne O Petritis; Matthew E Monroe; David G Camp; Stephen A Wood; William P Melega; Diana J Bigelow; Desmond J Smith; Wei-Jun Qian; Richard D Smith
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

5.  The role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: a locomotor analysis.

Authors:  Pamela Brambilla Bagatini; Lisiani Saur; Mariana Freitas Rodrigues; Guilherme Cardoso Bernardino; Mariana Fontoura Paim; Guilherme Peres Coelho; Daniele Vieira da Silva; Raquel Mattos de Oliveira; Helena Schirmer; André Arigony Souto; Mônica Ryff Moreira Roca Vianna; Léder Leal Xavier
Journal:  Invert Neurosci       Date:  2011-04-27

6.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

Review 7.  What causes cell death in Parkinson's disease?

Authors:  Amitabh Gupta; Valina L Dawson; Ted M Dawson
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

8.  Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.

Authors:  Qi-Min Wang; Yu-Yu Xu; Shang Liu; Ze-Gang Ma
Journal:  Oncotarget       Date:  2017-07-18

9.  NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.

Authors:  Rossana Sirabella; Maria Josè Sisalli; Giulia Costa; Katia Omura; Gaetano Ianniello; Annalisa Pinna; Micaela Morelli; Gianfranco Maria Di Renzo; Lucio Annunziato; Antonella Scorziello
Journal:  Cell Death Dis       Date:  2018-06-25       Impact factor: 8.469

10.  Raised activity of L-type calcium channels renders neurons prone to form paroxysmal depolarization shifts.

Authors:  Lena Rubi; Ulla Schandl; Michael Lagler; Petra Geier; Daniel Spies; Kuheli Das Gupta; Stefan Boehm; Helmut Kubista
Journal:  Neuromolecular Med       Date:  2013-05-22       Impact factor: 3.843

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.